No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Medical products group Convatec said on Tuesday that Jill McConnell will succeed Fiona Ryder as chief financial officer, with the appointment taking effect on 1 March 2027 following an orderly handover period.
McConnell will join the company as CFO-designate on 1 January and become a board director when she formally takes over the role two months later. Ryder will remain in post through Convatec's full-year results on 23 February before leaving the business at the end of February.
McConnell joins from US-listed clinical research company Fortrea, where she served as CFO and helped oversee its 2023 spin-off from Labcorp. She also held senior finance roles at Labcorp and GSK, including CFO positions at Labcorp Drug Development, ViiV Healthcare and GSK's US pharmaceuticals business.
Convatec said the appointment supports delivery of its Accelerate strategy and follows the announcement in July that Ryder would step down as part of a planned succession process. Ryder joined Convatec in 2022.
As of 1130 GMT, Convatec shares were down 0.73% at 243.80p.
Reporting by Iain Gilbert at Sharecast.com
See latest RNS at Sharecast
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.